Casandra
Casandra Test Code QD45199Version 1 (DRAFT)
Performing Lab
Bullous Pemphigoid BP230 Antibody
Also known as: Pemphigoid BP230 IgG, 230-kDa Bullous
Clinical Use
Order TestUse
To aid in the diagnosis of bullous pemphigoid (BP), a chronic blistering disorder characterized by tense blisters and erythema. Serum IgG antibodies to the basement membrane zone, specifically targeting BP230, are detected via ELISA and serve as a useful and specific serologic marker of disease.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (ELISA)
Biomarkers
BP230
ProteinConcentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
2-10 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Collection Instructions
Standard collection techniques.
Causes for Rejection
Gross hemolysis • Grossly lipemic • Grossly icteric • Contaminated specimens • Specimens improperly stored or handled
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 4 days |
| Refrigerated | 7 days |
| Frozen | 30 days |
Related Tests
Other tests from different labs that may be relevant
Bullous Pemphigoid, BP180 and BP230, IgG Antibodies, Serum
Mayo Clinic Lab
Bullous Pemphigoid (BP180 and BP230) Antibodies, IgG by ELISA
ARUP Laboratories
BP180 and BP230 (Bullous Pemphigoid), IgG Antibodies
Labcorp
Pemphigoid Antibody Panel
ARUP Laboratories
Basement Membrane Zone (Epithelial) Antibodies, IgG by IIF
ARUP Laboratories
Immunobullous Disease Antibody Panel
ARUP Laboratories
Basement Membrane Zone Antibody Panel
ARUP Laboratories
Antiskin Autoantibodies, Quantitative
Labcorp
Basement Membrane Zone (Epithelial) Antibodies, IgA by IIF
ARUP Laboratories
Cutaneous Immunofluorescence Antibodies, IgG and IgG4, Serum
Mayo Clinic Lab